Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • tedwong
    Member
    • Mar 2015
    • 13

    Beginner Questions

    I'm a beginner to the field. I'm trying to align my reads to a reference genome. However, I'm not quite sure I understand what tophat is trying to do. In fact, I want to make sure my understanding to RNA sequencing is correct.

    Let's say,

    "tophat -p 8 -G genes.gtf -o C1_R1_thout genome C1_R1_1.fq C1_R1_2.fq"

    From my understanding, the *.fq files are raw sequence reads generated by experiments. Those raw reads are aligned to sequences defined in a reference genome. The reference genome in this example is "genome". genes.gtf lists some known transcripts.

    The point of doing it is to analyse unknown transcripts. Say, if some of my reads can't be aligned to the reference genome, we know it might mean that there's a new mutation. Am I correct?

    Another question, why do we need to provide an annotation file (genes.gtf) to tophat? Tophat already has the information from the reference genome to align with?

    Thanks,
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Originally posted by tedwong View Post
    The point of doing it is to analyse unknown transcripts. Say, if some of my reads can't be aligned to the reference genome, we know it might mean that there's a new mutation. Am I correct?
    Tophat helps serve a few different and sometimes overlapping roles. Firstly, it will align the reads to known (annotated) transcripts. Secondly, it will align reads directly to the genome. Thirdly, it will attempt to align reads in such a way that finding novel (unannotated) transcripts is possible. For actually finding these, tools like cufflinks are useful.

    There are also many reasons a given read won't align to the the genome/transcriptome. Firstly, it could be from a contaminant (bacteria, etc.). This is extremely common. Secondly, it could be from a portion of the genome that doesn't exist in the reference sequence (e.g., the 45S rRNA sequence isn't in the mouse genome and there are a number of sequence gaps in most (all?) mammalian genomes). Thirdly, there may be variants in the sample that was sequenced that aren't present in the reference sequence (there's almost always some of this). Finally, this can be caused by sequencing errors.

    There are undoubtedly other reasons in addition to those I listed above!

    Another question, why do we need to provide an annotation file (genes.gtf) to tophat? Tophat already has the information from the reference genome to align with?
    Providing tophat with a reference annotation allows it to more easily align reads to the known transcriptome. Most of you reads will align either to that or to the genome, so this decreases the number of reads that need to be used to find novel splice sites. Finding these is somewhat computationally demanding and not without its issues.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...